Global initiative launched to map brain cells linked to diseases

In June 2026, the Allen Institute and 30 partners launched the Brain Health accelerator, a landmark global initiative to combat neurodegenerative diseases.

By moving beyond traditional molecular research, this project aims to map the precise brain cells and functional circuits that break down during illness.

This shift allows scientists to develop precision therapies designed to protect or restore specific, vulnerable components of the brain.

Utilizing cutting-edge technology like single-cell genomics and AI-based modeling, the initiative creates a human brain cell map comparable in scale to the Human Genome Project.

A key advantage is the collaborative network established to study human brain tissue, reducing reliance on animal models.

With over 3 billion people affected by neurological conditions worldwide, the urgency for new treatments is clear.

By adopting a 'radically open science' model, the project ensures that data is shared rapidly with researchers across the globe.